Cohance Lifesciences Ltd

BSE: 543064

41

total announcements

COHANCE.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 21 Oct 2026

Market Cap

₹17,511 Cr

P/E (TTM)

167.7

P/E (Forward)

47.2

EPS (TTM)

₹2.73

52W Low

₹266.70

52W High

₹917.85

Dividend Yield

0.00%

Beta

0.62

Price / Book

4.5

Debt / Equity

9.9

Revenue (TTM)

₹2,142 Cr

Gross Margin

70.36%

Operating Margin

-11.46%

BSECompany UpdateMgmt Change12 Oct 2026

Cohance Lifesciences Ltd

General updates

Cohance Lifesciences Ltd has received Central Government approval for the appointment of Mr. Umang Vohra as Chairman and Group CEO.

Read more →📎 1 attachment
BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has appointed a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateMgmt Change9 Oct 2026

COHANCE LIFESCIENCES LIMITED

COHANCE LIFESCIENCES LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

COHANCE LIFESCIENCES LIMITED has informed BSE about the appointment of a new Chief Financial Officer.

BSECompany UpdateRegulatory7 Oct 2026

Cohance Lifesciences Ltd

Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018

Cohance Lifesciences Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30 September 2026, confirming the details of securities dematerialized/rematerialized during the period.

Read more →📎 1 attachment
BSEInsider Trading / SAST28 Sept 2026

Cohance Lifesciences Ltd

Closure of Trading Window

Cohance Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives from 1 October 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending 30 September 2026.

Read more →📎 1 attachment
Page 1 of 3Next →